An anionic residue at position 564 is important for maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor.

Gonadotropin-independent, male-limited precocious puberty is caused by a variety of mutations in the lutropin/choriogonadotropin receptor (LHR) that produce constitutive receptor activation. Two of these mutations encode replacement of conserved aspartate residues at positions 564 and 578 with glycine. We previously used site-directed mutagenesis to study the functional role of the Asp578 side chain in transmembrane helix 6, and concluded that it is its ability to serve as a properly positioned interhelical hydrogen bond acceptor, rather than its negative charge, that is important for stabilizing the inactive state of the LHR. We now report the effects of substituting seven different amino acids for the Asp564 residue located at the carboxyl terminus of the third intracellular loop. Glycine, alanine, valine, leucine, phenylalanine, and asparagine produced constitutive activation in a COS-7 cell expression system (3-5-fold increase in basal cAMP), but glutamate did not, indicating that a negative charge at position 564 may be important for maintaining the inactive LHR conformation. Characterization of double-mutant receptors showed that certain substitutions at Asp564 and Asp578 have a cumulative effect on basal receptor activity, perhaps because they mimic different aspects of the activation process normally triggered by hormone binding.

[1]  J. Baldwin,et al.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.

[2]  A. Shenker,et al.  A model of the lutropin/choriogonadotropin receptor: insights into the structural and functional effects of constitutively activating mutations. , 1997, Protein engineering.

[3]  A. Scheer,et al.  The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Perez,et al.  Synergism of constitutive activity in alpha 1-adrenergic receptor activation. , 1997, Biochemistry.

[5]  A. Shenker,et al.  The Role of Asp578 in Maintaining the Inactive Conformation of the Human Lutropin/Choriogonadotropin Receptor* , 1996, The Journal of Biological Chemistry.

[6]  T. Sakmar,et al.  Functional Interaction of Transmembrane Helices 3 and 6 in Rhodopsin , 1996, The Journal of Biological Chemistry.

[7]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[8]  H. Khorana,et al.  Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.

[9]  B. Kobilka,et al.  Transmembrane Regions V and VI of the Human Luteinizing Hormone Receptor Are Required for Constitutive Activation by a Mutation in the Third Intracellular Loop* , 1996, The Journal of Biological Chemistry.

[10]  A. Parfitt,et al.  Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. , 1996, The New England journal of medicine.

[11]  Martin Tj Actions of Parathyroid Hormone–Related Peptide and Its Receptors , 1996 .

[12]  R. Gilchrist,et al.  The Luteinizing Hormone/Chorionic Gonadotropin Receptor Has Distinct Transmembrane Conductors for cAMP and Inositol Phosphate Signals* , 1996, The Journal of Biological Chemistry.

[13]  J. Spudich,et al.  Shuttling between two protein conformations: the common mechanism for sensory transduction and ion transport. , 1996, Current opinion in cell biology.

[14]  R. Kraaij Expression and Activation of Gonadotropin Receptors , 1996 .

[15]  J. Konopka,et al.  Mutation of Pro-258 in transmembrane domain 6 constitutively activates the G protein-coupled alpha-factor receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Brunner,et al.  Luteinizing hormone receptor mutations and sex differentiation. , 1996, European journal of endocrinology.

[17]  J. Stankova,et al.  Mutations of Two Adjacent Amino Acids Generate Inactive and Constitutively Active Forms of the Human Platelet-activating Factor Receptor (*) , 1996, The Journal of Biological Chemistry.

[18]  E. Nieschlag,et al.  An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. , 1996, The Journal of clinical endocrinology and metabolism.

[19]  J. Wess,et al.  Molecular Mechanisms Involved in Muscarinic Acetylcholine Receptor-mediated G Protein Activation Studied by Insertion Mutagenesis (*) , 1996, The Journal of Biological Chemistry.

[20]  B. Bormann,et al.  Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB-2 receptor , 1996, Nature Structural Biology.

[21]  S. Swillens,et al.  Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. , 1996, The Journal of clinical endocrinology and metabolism.

[22]  M. Brann,et al.  Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis. , 1995, The Journal of pharmacology and experimental therapeutics.

[23]  H. Brunner,et al.  A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. , 1995, The Journal of clinical endocrinology and metabolism.

[24]  H Weinstein,et al.  Related Contribution of Specific Helix 2 and 7 Residues to Conformational Activation of the Serotonin 5-HT2A Receptor (*) , 1995, The Journal of Biological Chemistry.

[25]  W. Sadee,et al.  Activating and Inactivating Mutations in N- and C-terminal i3 Loop Junctions of Muscarinic Acetylcholine Hm1 Receptors (*) , 1995, The Journal of Biological Chemistry.

[26]  L. Blomberg,et al.  Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. K. Ackers,et al.  Long-range, small magnitude nonadditivity of mutational effects in proteins. , 1995, Biochemistry.

[28]  K. Fahmy,et al.  A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. , 1994, The Journal of biological chemistry.

[29]  T. Minegishi,et al.  A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty , 1993, Nature.

[30]  J. Parma,et al.  Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas , 1993, Nature.

[31]  A. Shenker,et al.  Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation. , 1993, Molecular endocrinology.

[32]  R. Lefkowitz,et al.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.

[33]  D. Oprian,et al.  Constitutive activation of opsin: influence of charge at position 134 and size at position 296. , 1993, Biochemistry.

[34]  M. Ascoli,et al.  The lutropin/choriogonadotropin receptor ... 4 years later. , 1993, Endocrine reviews.

[35]  David J Weber,et al.  Quantitative interpretations of double mutations of enzymes. , 1992, Archives of biochemistry and biophysics.

[36]  T. Gudermann,et al.  Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells. , 1992, The Journal of biological chemistry.

[37]  M. Caron,et al.  Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. , 1988, The Journal of biological chemistry.

[38]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[39]  M. Ascoli,et al.  Mutation of a highly conserved acidic residue present in the second intracellular loop of G-protein-coupled receptors does not impair hormone binding or signal transduction of the luteinizing hormone/chorionic gonadotropin receptor. , 1993, Molecular endocrinology.

[40]  W. C. Probst,et al.  Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.